KemPharm

$6.48 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About KemPharm

KemPharm Inc. provides biopharmaceutical services. The Company offers discovery and development of therapies for the treatment of attention deficit hyperactivity disorder (ADHD), pain, and cardiovascular diseases.

Stock Analysis

last close $7.03
1-mo return -15.4%
3-mo return -29.8%
avg daily vol. 444.73T
52-week high 18.15
52-week low 5.86
market cap. $289M
forward pe -
annual div. -
roe -30.9%
ltg forecast -
dividend yield -
annual rev. $28M
inst own. 25.9%
baraka

Subscribe now for daily local and international financial news

Subscribe